Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
53.24
+1.35 (2.60%)
Jul 22, 2025, 3:10 PM - Market open
Globus Medical Revenue
Globus Medical had revenue of $598.12M in the quarter ending March 31, 2025, a decrease of -1.41%. This brings the company's revenue in the last twelve months to $2.51B, up 32.26% year-over-year. In the year 2024, Globus Medical had annual revenue of $2.52B with 60.62% growth.
Revenue (ttm)
$2.51B
Revenue Growth
+32.26%
P/S Ratio
2.81
Revenue / Employee
$473,738
Employees
5,300
Market Cap
7.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GMED News
- 1 day ago - Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results - GlobeNewsWire
- 4 days ago - Globus Medical Schedules Second Quarter Earnings Release and Conference Call - GlobeNewsWire
- 6 days ago - Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue - GlobeNewsWire
- 19 days ago - Globus Medical: Obtaining My Backing Again - Seeking Alpha
- 2 months ago - Globus Medical Announces $500 Million Share Repurchase Program - GlobeNewsWire
- 2 months ago - Medical, Inc. Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 2 months ago - Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Globus Medical Reports First Quarter 2025 Results - GlobeNewsWire